ATE420633T1 - Zusammensetzung und ihre verwendung zur behandlung von neuropathischem verlust der sensibilität - Google Patents
Zusammensetzung und ihre verwendung zur behandlung von neuropathischem verlust der sensibilitätInfo
- Publication number
- ATE420633T1 ATE420633T1 AT03796465T AT03796465T ATE420633T1 AT E420633 T1 ATE420633 T1 AT E420633T1 AT 03796465 T AT03796465 T AT 03796465T AT 03796465 T AT03796465 T AT 03796465T AT E420633 T1 ATE420633 T1 AT E420633T1
- Authority
- AT
- Austria
- Prior art keywords
- nsp
- anesthetic
- neuropathic
- sensitivity
- loss
- Prior art date
Links
- 230000002981 neuropathic effect Effects 0.000 title 1
- 230000035945 sensitivity Effects 0.000 title 1
- 230000003444 anaesthetic effect Effects 0.000 abstract 4
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 abstract 2
- 230000001953 sensory effect Effects 0.000 abstract 2
- 239000005711 Benzoic acid Substances 0.000 abstract 1
- NNJVILVZKWQKPM-UHFFFAOYSA-N Lidocaine Chemical compound CCN(CC)CC(=O)NC1=C(C)C=CC=C1C NNJVILVZKWQKPM-UHFFFAOYSA-N 0.000 abstract 1
- 235000010233 benzoic acid Nutrition 0.000 abstract 1
- 230000003247 decreasing effect Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 229960004194 lidocaine Drugs 0.000 abstract 1
- 230000009023 proprioceptive sensation Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
- A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
- A61K31/245—Amino benzoic acid types, e.g. procaine, novocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Emergency Medicine (AREA)
- Dermatology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US42920802P | 2002-11-26 | 2002-11-26 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE420633T1 true ATE420633T1 (de) | 2009-01-15 |
Family
ID=32393523
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03796465T ATE420633T1 (de) | 2002-11-26 | 2003-11-25 | Zusammensetzung und ihre verwendung zur behandlung von neuropathischem verlust der sensibilität |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP1565173B1 (de) |
| JP (1) | JP2006509766A (de) |
| CN (1) | CN1717229A (de) |
| AT (1) | ATE420633T1 (de) |
| AU (1) | AU2003298710B2 (de) |
| CA (1) | CA2507217C (de) |
| DE (1) | DE60325885D1 (de) |
| ES (1) | ES2319764T3 (de) |
| WO (1) | WO2004047819A2 (de) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7718674B2 (en) | 2004-09-27 | 2010-05-18 | Bridge Pharma, Inc. | Methods of relieving neuropathic pain with the S-isomer of 2-{2[N-(2-indanyl)-N-phenylamino]ethyl}piperidine |
| WO2008011161A2 (en) | 2006-07-21 | 2008-01-24 | Bridge Pharma, Inc. | Dermal anesthetic compounds |
| WO2010017626A1 (en) * | 2008-08-13 | 2010-02-18 | Origin Biomed Inc. | Compositions comprising terpene compounds for treating negative sensory phenomena |
| RU2497679C2 (ru) | 2008-10-02 | 2013-11-10 | Милан Инк. | Способ получения многослойного клеящегося ламинированного материала |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5993018A (ja) * | 1982-11-18 | 1984-05-29 | Sumitomo Chem Co Ltd | 顔面錯感覚症治療薬 |
| US5234957A (en) * | 1991-02-27 | 1993-08-10 | Noven Pharmaceuticals, Inc. | Compositions and methods for topical administration of pharmaceutically active agents |
-
2003
- 2003-11-25 EP EP03796465A patent/EP1565173B1/de not_active Expired - Lifetime
- 2003-11-25 AT AT03796465T patent/ATE420633T1/de not_active IP Right Cessation
- 2003-11-25 AU AU2003298710A patent/AU2003298710B2/en not_active Ceased
- 2003-11-25 DE DE60325885T patent/DE60325885D1/de not_active Expired - Lifetime
- 2003-11-25 CA CA2507217A patent/CA2507217C/en not_active Expired - Fee Related
- 2003-11-25 CN CNA2003801041719A patent/CN1717229A/zh active Pending
- 2003-11-25 WO PCT/US2003/037815 patent/WO2004047819A2/en not_active Ceased
- 2003-11-25 ES ES03796465T patent/ES2319764T3/es not_active Expired - Lifetime
- 2003-11-25 JP JP2004555767A patent/JP2006509766A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| AU2003298710A1 (en) | 2004-06-18 |
| CA2507217A1 (en) | 2004-06-10 |
| CN1717229A (zh) | 2006-01-04 |
| DE60325885D1 (de) | 2009-03-05 |
| WO2004047819A3 (en) | 2004-07-29 |
| EP1565173B1 (de) | 2009-01-14 |
| CA2507217C (en) | 2012-08-28 |
| AU2003298710B2 (en) | 2008-02-07 |
| WO2004047819A2 (en) | 2004-06-10 |
| ES2319764T3 (es) | 2009-05-12 |
| EP1565173A2 (de) | 2005-08-24 |
| JP2006509766A (ja) | 2006-03-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60236413D1 (de) | Inhibitoren von hmgb1 zur behandlung von gewebekrankheiten | |
| ATE276749T1 (de) | Zusammensetzungen zur vorbeugung und behandlung der erkältung und grippe-artiger symptome und ihre verwendung | |
| ATE462427T1 (de) | Verwendung von treprostinil zur behandlung von neuropathischen diabetischen fussgeschwüren | |
| NO20093464L (no) | Nye medikamentblandinger basert pa anti-cholinergisk effektive forbindelser og beta-mimetika | |
| IS8058A (is) | Sýklísk súlfónamíð til að hamla gamma seytiasa | |
| MA28935B1 (fr) | Preparation et utilisation de derives de biphenyl-4-yl-carbonylamino-acide dans le traitement de l'obesite | |
| DE69213814D1 (de) | Melatoninderivate zur Behandlung von Schlafstörungen und zur Pre-Anästhesie | |
| DE59409312D1 (de) | Imidazopyridine und ihre anwendung zur behandlung von magen-darm krankheiten | |
| DE60037394D1 (de) | VERWENDUNG VON p53 INHIBITOREN ZUR BEHANDLUNG VON NEBENERSCHEINUNGEN BEI DER KREBSTHERAPIE | |
| ATE443043T1 (de) | Phenylcarboxamide als beta-sekretase-hemmer zur behandlung von alzheimer | |
| TNSN02022A1 (fr) | Triazolopyridines anti-inflammatoires nouvelles, et compositions les contenant | |
| ATE207351T1 (de) | Verwendung vonmodafinil zur behandlung von atemstillstand im schlaf und zentral erregten atembeschwerden | |
| ATE367387T1 (de) | Verwendung von oxindolderivaten zur behandlung von mit demenz in zusammenhang stehenden krankheiten, alzheimer-krankheit und mit glycogensynthasekinase-3 assoziierten leiden | |
| EP1543158A4 (de) | Regulierte aptamer-therapeutika | |
| SE0102147D0 (sv) | New methods | |
| ATE400277T1 (de) | Pharmazeutische zusammenstellung zur vorbeugung und behandlung von mit zellkrankheiten des augenhintergrundes zusammenhängenden krankheiten | |
| DE60224004D1 (de) | Verwendung von il-18 hemmern zur behandlung und/oder prävention von herzkrankheiten | |
| DE60325885D1 (de) | Zusammensetzung und ihre verwendung zur behandlung | |
| ATE333452T1 (de) | 4-(penylpiperidin-4-ylidenmethyl)benzamidderiva e und deren verwendung zur behandlung von schmerzen,angstzuständen oder erkrankungen des magen-darm- trakts | |
| ATE542542T1 (de) | Verwendung von gp130 aktivatoren zur behandlung von diabetischer neuropathie | |
| ATE375152T1 (de) | Behandlung von gastrointestinalen erkrankungen mit n-2,3,3-tetramethylbicyclo[2.2.1]heptan-2- amine | |
| BRPI0410657A (pt) | composto, composição farmacêutica, uso de um composto, método para tratar um distúrbio de um paciente, e, processo para a preparação de um composto | |
| ATE404203T1 (de) | Verwendung von desoxypeganin zur behandlung der klinischen depression | |
| ATE287400T1 (de) | 4-(phenylpiperidin-4-ylidenmethyl) benzamidderivate und deren verwendung zur behandlung von schmerzen, angst oder gastrointestinalen störungen | |
| ATE313528T1 (de) | 4-(phenyl(piperidin-4-yl)amino) benzamidderivate und deren verwendung zur behandlung von schmerzen,angst oder gastrointestinalen störungen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |